Côd QR

Valproate, risperidone, and paliperidone: A case of valproate-induced hyperammonemic encephalopathy

Hyperammonemia is a well-known adverse effect of valproate that can progress to a potentially fatal condition known as valproate-induced hyperammonemic encephalopathy (VHE). VHE is more common when valproate is used in combination therapy with other antiepileptic medications. A growing number of cas...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Kyle Wesselman, PharmD candidate, MA, BS, Vincent Cavaliere, PharmD, MM, BCPP, Rakesh Goyal, MD, Eric Anderson, MD, MBA, FAPA
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Association of Psychiatric Pharmacists 2024-02-01
Cyfres:Mental Health Clinician
Pynciau:
valproate
encephalopathy
vhe
risperidone
paliperidone palmitate
Mynediad Ar-lein:https://theijpt.org/doi/pdf/10.9740/mhc.2024.02.028
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg